203 related articles for article (PubMed ID: 32440782)
1. Understanding Concomitant Physical and Chemical Transformations of Simvastatin During Dry Ball Milling.
Modhave D; Saraf I; Karn A; Paudel A
AAPS PharmSciTech; 2020 May; 21(5):152. PubMed ID: 32440782
[TBL] [Abstract][Full Text] [Related]
2. Solid-State Reactivity of Mechano-Activated Simvastatin: Atypical Relation to Powder Crystallinity.
Modhave D; Laggner P; Brunsteiner M; Paudel A
J Pharm Sci; 2019 Oct; 108(10):3272-3280. PubMed ID: 31173762
[TBL] [Abstract][Full Text] [Related]
3. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation.
Lu W; Rades T; Rantanen J; Chan HK; Yang M
Int J Pharm; 2019 Dec; 572():118724. PubMed ID: 31678523
[TBL] [Abstract][Full Text] [Related]
4. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.
Branham ML; Moyo T; Govender T
Eur J Pharm Biopharm; 2012 Jan; 80(1):194-202. PubMed ID: 21906676
[TBL] [Abstract][Full Text] [Related]
5. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in Simvastatin: Twinning, Disorder, and Enantiotropic Phase Transitions.
Simões RG; Bernardes CES; Joseph A; M Piedade MF; Kraus W; Emmerling F; Diogo HP; Minas da Piedade ME
Mol Pharm; 2018 Nov; 15(11):5349-5360. PubMed ID: 30230340
[TBL] [Abstract][Full Text] [Related]
7. Amorphization of different furosemide polymorphic forms during ball milling: Tracking solid-to-solid phase transformations.
Wang M; Gong J; Rades T; Martins ICB
Int J Pharm; 2023 Dec; 648():123573. PubMed ID: 37931725
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying.
Craye G; Löbmann K; Grohganz H; Rades T; Laitinen R
Molecules; 2015 Dec; 20(12):21532-48. PubMed ID: 26633346
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127.
Karolewicz B; Gajda M; Owczarek A; Pluta J; Górniak A
Pharmazie; 2014 Aug; 69(8):589-94. PubMed ID: 25158569
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin-Nicotinamide Co-Crystals: Formation, Pharmaceutical Characterization and in vivo Profile.
Khan FM; Ahmad M; Idrees HA
Drug Des Devel Ther; 2020; 14():4303-4313. PubMed ID: 33116417
[TBL] [Abstract][Full Text] [Related]
11. [The development of co-amorphous drug systems].
Yao J; Shi NQ; Wang XL
Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
[TBL] [Abstract][Full Text] [Related]
12. Milling induced amorphisation and recrystallization of α-lactose monohydrate.
Badal Tejedor M; Pazesh S; Nordgren N; Schuleit M; Rutland MW; Alderborn G; Millqvist-Fureby A
Int J Pharm; 2018 Feb; 537(1-2):140-147. PubMed ID: 29262302
[TBL] [Abstract][Full Text] [Related]
13. A stable amorphous statin: solid-state NMR and dielectric studies on dynamic heterogeneity of simvastatin.
Nunes TG; Viciosa MT; Correia NT; Danède F; Nunes RG; Diogo HP
Mol Pharm; 2014 Mar; 11(3):727-37. PubMed ID: 24499472
[TBL] [Abstract][Full Text] [Related]
14. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
Mohammad MA; Grimsey IM; Forbes RT
J Pharm Biomed Anal; 2015 Oct; 114():176-83. PubMed ID: 26068908
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin.
Trasi NS; Boerrigter SX; Byrn SR
Pharm Res; 2010 Jul; 27(7):1377-89. PubMed ID: 20490628
[TBL] [Abstract][Full Text] [Related]
16. Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations.
Ambike AA; Mahadik KR; Paradkar A
Pharm Res; 2005 Jun; 22(6):990-8. PubMed ID: 15948043
[TBL] [Abstract][Full Text] [Related]
17. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
[TBL] [Abstract][Full Text] [Related]
18. Influence of Crystal Disorder on the Forced Oxidative Degradation of Vortioxetine HBr.
Modhave D; Barrios B; Iyer J; Paudel A
AAPS PharmSciTech; 2023 Dec; 25(1):10. PubMed ID: 38158448
[TBL] [Abstract][Full Text] [Related]
19. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
Feng T; Bates S; Carvajal MT
Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
